Letter: a promising Helicobacter pylori regimen-vonoprazan-based therapy. Author's reply. Ang D. Aliment Pharmacol Ther 2022;56:754-755.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Ang D. Letter: a promising Helicobacter pylori regimen-vonoprazan-based therapy. Author's reply. Aliment Pharmacol Ther 2022;56:754-755.
PMID: 35879904